These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 16387070
1. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome. Berber I, Aydin C, Yigit B, Turkmen F, Titiz IM, Altaca G. Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070 [Abstract] [Full Text] [Related]
2. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F, Bunnapradist S, Martin P. J Nephrol; 2002 Dec; 15(6):605-13. PubMed ID: 12495272 [Abstract] [Full Text] [Related]
3. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors. Sumethkul V, Ingsathit A, Jirasiritham S. Transplant Proc; 2009 Dec; 41(1):213-5. PubMed ID: 19249516 [Abstract] [Full Text] [Related]
4. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings. Veroux M, Puliatti C, Macarone M, Cappello D, Gagliano M, Spataro M, Di Mare M, Giuffrida G, Veroux P. Transplant Proc; 2005 Dec; 37(6):2467-8. PubMed ID: 16182711 [Abstract] [Full Text] [Related]
5. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M. Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [Abstract] [Full Text] [Related]
6. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J. Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430 [Abstract] [Full Text] [Related]
7. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts. Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B. Clin Transplant; 2011 Oct; 25(1):E77-81. PubMed ID: 21039887 [Abstract] [Full Text] [Related]
8. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients. Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P. Transplant Proc; 2005 Oct; 37(6):2574-5. PubMed ID: 16182748 [Abstract] [Full Text] [Related]
9. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment. Kim JA, Huh W, Lee KW, Kim SJ, Kim YG, Kim DJ, Joh JW, Oh HY. Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352 [Abstract] [Full Text] [Related]
10. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK. Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336 [Abstract] [Full Text] [Related]
11. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW. Clin Transplant; 2006 Nov; 20(3):369-73. PubMed ID: 16824156 [Abstract] [Full Text] [Related]
13. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J. Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375 [Abstract] [Full Text] [Related]
14. HBsAg(+) donor as a kidney transplantation deceased donor. Wei HK, Loong CC, King KL, Wu CW, Lui WY. Transplant Proc; 2008 Sep; 40(7):2097-9. PubMed ID: 18790163 [Abstract] [Full Text] [Related]
15. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD. Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824 [Abstract] [Full Text] [Related]
16. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK. Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774 [Abstract] [Full Text] [Related]
17. Changes in serological markers of hepatitis B virus after renal transplantation. Urbini Dos Santos C, Sevá-Pereira T, Alves-Filho G, Lorena SL, Soares EC, Mazzali M. Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006 [Abstract] [Full Text] [Related]
18. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation]. Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS. Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765 [Abstract] [Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
20. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M, Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups. Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]